ONMDNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as ONMDW
OneMedNet Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$4.62+0.11 (+2.44%)
Close on Oct 19, 2026
- Market cap
- $268.05M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
10M
Shares held, 13F filers
Institutional holders
22
6 new, 4 sold out
Net institutional buying
7M
In Q2 2026
Insider trades, 12 months
12 buys · 1 sales
Net bought $3.12M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Off the Chain LP | 3,215,650 | 9.50% | 13G (passive) | Sep 25, 2024 |
| Td Securities (USA) LLC | 3,025,338 | 6.20% | 13G (passive) amendment | Sep 30, 2025 |
| Cowen and Company, LLC | 2,970,836 | 9.50% | 13G (passive) | Sep 30, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ONMD | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Savant Capital, LLC | 7,219,243 | – | $5.14M | New | 0.02% |
| Vanguard Capital Management LLC | 1,152,210 | – | $819.22K | +36,645 | 0.00% |
| Geode Capital Management, LLC | 334,332 | – | $237.71K | −4,196 | 0.00% |
| Vanguard Fiduciary Trust Co | 137,706 | – | $97.91K | +1,093 | 0.00% |
| BlackRock, Inc. | 120,980 | – | $86.02K | +50,884 | 0.00% |
| State Street Corp | 116,700 | – | $82.97K | – | 0.00% |
| Discovery Capital Management, LLC / Ct | 112,252 | – | $79.81K | – | 0.00% |
| PNC Financial Services Group, Inc. | 103,332 | – | $73.47K | +86,072 | 0.00% |
| OpenArc Corporate Advisory, LLC | 97,413 | – | $69.26K | +86,071 | 0.00% |
| Northern Trust Corp | 46,835 | – | $33.30K | −8,109 | 0.00% |
| Captrust Financial Advisors | 32,600 | – | $23.18K | New | 0.00% |
| Ashton Thomas Private Wealth, LLC | 26,596 | – | $18.91K | – | 0.00% |
| Toronto Dominion Bank | 23,599 | – | $16.78K | New | 0.00% |
| Neuberger Berman Group LLC | 19,504 | – | $13.87K | – | 0.00% |
| UBS Group AG | 16,135 | – | $11.47K | −100 | 0.00% |
| Hrt Financial LP | 15,628 | – | $11 | −28,452 | 0.00% |
| Procyon Advisors, LLC | 13,814 | – | $9.82K | – | 0.00% |
| Raymond James Financial Inc | 12,100 | – | $8.60K | – | 0.00% |
| Morgan Stanley | 11,821 | – | $8.41K | New | 0.00% |
| Commonwealth Equity Services, LLC | 11,000 | – | $7.82K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 22 | 10M | 6 / 5 | 4 / 4 | 8M | 0M |
| Q1 2026 | 21 | 11M | 6 / 7 | 1 / 7 | 6M | 0M |
| Q4 2025 | 23 | 6M | 10 / 7 | 3 / 4 | 1M | 7M |
| Q3 2025 | 17 | 12M | 6 / 5 | 2 / 4 | 7M | 0M |
| Q2 2025 | 15 | 5M | 3 / 2 | 3 / 5 | 0M | 0M |
| Q1 2025 | 17 | 5M | 2 / 4 | 7 / 2 | 1M | 0M |
| Q4 2024 | 17 | 4M | 2 / 3 | 7 / 5 | 0M | 2M |
| Q3 2024 | 20 | 6M | 9 / 2 | 6 / 3 | 2M | 1M |
| Q2 2024 | 14 | 4M | 11 / 3 | 0 / 4 | 3M | 0M |
| Q1 2024 | 7 | 1M | 4 / 2 | 1 / 3 | 1M | 0M |
| Q4 2023 | 6 | 0M | 6 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ONMD | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 845,040 | – | $600.82K | 0.00% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 307,170 | – | $218.40K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 158,498 | – | $122.14K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 47,503 | – | $33.77K | 0.00% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 43,207 | – | $33.30K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 41,177 | – | $31.73K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 29,823 | – | $22.98K | 0.00% | May 31, 2026 |
| 1290 VT Micro Cap Portfolio | 3,381 | – | $2.40K | 0.00% | Jun 30, 2026 |
| Avantis Total Equity Markets ETF | 909 | – | $700 | 0.00% | May 31, 2026 |
| Blackstone Alternative Multi-Strategy Fund | -6,069 | – | -$4.32K | -0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Jeffrey Yu | Chief Medical Officer, Director, 10% owner | 10,235,237 | Sep 14, 2026 |
| Aaron Green | Chief Executive Officer, Director | 1,896,375 | Jun 24, 2026 |
| Thomas Kosasa | Director, 10% owner | 18,538,150 | Aug 7, 2026 |
| Robert Lawrence Golden | Director | 547,905 | Nov 26, 2025 |
| Jair Clarke | Director | 138,485 | Nov 26, 2025 |
| Sherry Coonse McCraw | Director | 56,342 | Nov 26, 2025 |
| Eric Casaburi | Director | 110,475 | Nov 26, 2025 |
| Kenneth Alleyne | Director | 38,219 | Nov 26, 2025 |
| Andrew B. Zeinfeld | Director | 381,525 | Nov 26, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jeffrey Yu Chief Medical Officer, Director, 10% owner | Sep 10, 2026 | Buy | +142,857 | $0.63 | $90.00K | 8,923,267 |
| Thomas Kosasa Director, 10% owner | Jul 30, 2026 | Buy | +1,449,275 | $0.69 | $1,000.00K | 18,538,150 |
| Aaron Green Chief Executive Officer, Director | Jun 23, 2026 | Buy | +36,650 | $0.57 | $20.89K | 1,896,375 |
| Jeffrey Yu Chief Medical Officer, Director, 10% owner | Jun 23, 2026 | Buy | +158,730 | $0.63 | $100.00K | 8,780,410 |
| Jeffrey Yu Chief Medical Officer, Director, 10% owner | Jun 16, 2026 | Buy | +172,414 | $0.58 | $100.00K | 8,621,680 |
| Aaron Green Chief Executive Officer, Director | Jun 15, 2026 | Buy | +18,702 | $0.54 | $10.10K | 1,859,725 |
| Aaron Green Chief Executive Officer, Director | Jun 12, 2026 | Buy | +36,920 | $0.56 | $20.68K | 1,841,023 |
| Thomas Kosasa Director, 10% owner | Jun 12, 2026 | Buy | +158,730 | $0.63 | $100.00K | 17,088,874 |
| Thomas Kosasa Director, 10% owner | May 18, 2026 | Buy | +268,817 | $0.93 | $250.00K | 16,930,144 |
| Thomas Kosasa Director, 10% owner | Apr 23, 2026 | Buy | +280,898 | $0.89 | $250.00K | 16,661,327 |
| Jeffrey Yu Chief Medical Officer, Director, 10% owner | Apr 1, 2026 | Award | +219,429 | $0.83 | $182.13K | 8,449,266 |
| Jeffrey Yu Chief Medical Officer, Director, 10% owner | Apr 1, 2026 | Buy | +903,614 | $0.83 | $750.00K | 8,229,837 |
| Thomas Kosasa Director, 10% owner | Feb 6, 2026 | Buy | +595,238 | $0.84 | $500.00K | 16,380,429 |
| Eric Casaburi Director | Nov 26, 2025 | Award | +45,000 | – | – | 110,475 |
| Kenneth Alleyne Director | Nov 26, 2025 | Award | +38,219 | – | – | 38,219 |
| Jair Clarke Director | Nov 26, 2025 | Award | +45,000 | – | – | 138,485 |
| Jeffrey Yu Chief Medical Officer, Director | Nov 26, 2025 | Award | +45,000 | – | – | 7,326,223 |
| Sherry Coonse McCraw Director | Nov 26, 2025 | Award | +45,000 | – | – | 56,342 |
| Thomas Kosasa Director | Nov 26, 2025 | Award | +45,000 | – | – | 15,785,191 |
| Andrew B. Zeinfeld Director | Nov 26, 2025 | Award | +45,000 | – | – | 381,525 |
| Aaron Green Chief Executive Officer, Director | Nov 26, 2025 | Award | +45,000 | – | – | 1,930,425 |
| Robert Lawrence Golden Chief Financial Officer, Director | Nov 26, 2025 | Award | +45,000 | – | – | 547,905 |
| Jeffrey Yu Chief Medical Officer, Director | Nov 24, 2025 | Award | +200,000 | – | – | 7,281,223 |
| Aaron Green Chief Executive Officer, Director | Nov 24, 2025 | Award | +1,000,000 | – | – | 1,885,425 |
| Robert Lawrence Golden Chief Financial Officer, Director | Nov 24, 2025 | Award | +33,333 | – | – | 502,905 |
| Robert Lawrence Golden Chief Financial Officer, Director | Nov 24, 2025 | Award | +300,000 | – | – | 469,572 |
| Aaron Green Chief Executive Officer, Director | Nov 18, 2025 | Sale | −61,555 | $1.20 | $73.87K | 1,804,103 |
| Aaron Green Chief Executive Officer, Director | Oct 22, 2025 | Sale | −64,767 | $2.23 | $144.43K | 1,865,658 |
| Eric Casaburi Director | Oct 15, 2025 | Buy | +10,000 | $3.05 | $30.50K | 65,475 |
| Jeffrey Yu Chief Medical Officer, Director | Sep 25, 2025 | Buy | +1,250 | $1.03 | $1.29K | 7,081,223 |
| Jeffrey Yu Chief Medical Officer, Director | Sep 24, 2025 | Buy | +17,200 | $1.02 | $17.54K | 7,079,973 |
| Thomas Kosasa Director | Sep 24, 2025 | Buy | +6,000 | $0.93 | $5.58K | 15,740,191 |
| Jeffrey Yu Chief Medical Officer, Director | Sep 23, 2025 | Buy | +5,700 | $0.93 | $5.30K | 7,062,773 |
| Jeffrey Yu Chief Medical Officer, Director | Sep 22, 2025 | Buy | +400 | $0.95 | $380 | 7,057,073 |
| Jeffrey Yu Chief Medical Officer, Director | Sep 19, 2025 | Buy | +1,250 | $0.89 | $1.11K | 7,056,673 |
| Jeffrey Yu Chief Medical Officer, Director | Sep 18, 2025 | Buy | +700 | $0.91 | $637 | 7,055,423 |
| Jeffrey Yu Chief Medical Officer, Director | Sep 5, 2025 | Buy | +2,100 | $0.86 | $1.81K | 7,054,723 |
| Jeffrey Yu Chief Medical Officer, Director | Sep 4, 2025 | Buy | +11,810 | $0.87 | $10.27K | 7,052,623 |
| Jeffrey Yu Chief Medical Officer, Director | Sep 3, 2025 | Buy | +11,670 | $0.81 | $9.45K | 7,040,813 |
| Jeffrey Yu Chief Medical Officer, Director | Sep 2, 2025 | Buy | +24,319 | $0.85 | $20.67K | 7,029,143 |
| Jeffrey Yu Chief Medical Officer, Director | Aug 29, 2025 | Buy | +10,890 | $0.82 | $8.93K | 7,004,824 |
| Thomas Kosasa Director | Aug 29, 2025 | Buy | +581,395 | $0.86 | $500.00K | 15,734,191 |
| Jeffrey Yu Chief Medical Officer, Director | Aug 28, 2025 | Buy | +17,000 | $0.80 | $13.60K | 6,993,934 |
| Jeffrey Yu Chief Medical Officer, Director | Aug 27, 2025 | Buy | +21,374 | $0.69 | $14.75K | 6,976,934 |
| Jeffrey Yu Chief Medical Officer, Director | Aug 26, 2025 | Buy | +173,350 | $0.69 | $119.61K | 6,955,560 |
| Jeffrey Yu Chief Medical Officer, Director | Aug 25, 2025 | Buy | +13,300 | $0.75 | $9.98K | 6,782,210 |
| Jeffrey Yu Chief Medical Officer, Director | Aug 21, 2025 | Buy | +15,000 | $0.77 | $11.55K | 6,768,910 |
| Jeffrey Yu Chief Medical Officer, Director | Aug 19, 2025 | Buy | +16,500 | $0.77 | $12.71K | 6,753,910 |
| Jeffrey Yu Chief Medical Officer, Director | Jun 20, 2025 | Buy | +1,666,666 | $0.42 | $700.00K | 6,737,410 |
| Thomas Kosasa Director | Jun 20, 2025 | Buy | +1,190,476 | $0.42 | $500.00K | 15,152,796 |
| Jeffrey Yu Chief Medical Officer, Director | Jun 19, 2025 | Conversion | +1,828,279 | $0.71 | $1.30M | 5,070,744 |
| Thomas Kosasa Director | Jun 19, 2025 | Conversion | +2,865,016 | $0.71 | $2.03M | 13,962,320 |
| Thomas Kosasa Director | Jun 19, 2025 | Conversion | +2,123,424 | $0.75 | $1.59M | 11,097,304 |
| Jeffrey Yu Chief Medical Officer, Director | Jun 17, 2025 | Conversion | +479,270 | $1.14 | $546.37K | 3,242,465 |
| Thomas Kosasa Director | Jun 17, 2025 | Conversion | +493,056 | $1.14 | $562.08K | 8,973,880 |
| Aaron Green Chief Executive Officer, Director | Jun 17, 2025 | Conversion | +240,425 | $1.14 | $274.08K | 885,425 |
| Thomas Kosasa Director | Jun 16, 2025 | Buy | +55,000 | $0.38 | $20.90K | 8,480,824 |
| Thomas Kosasa Director | Apr 21, 2025 | Buy | +47,000 | $0.49 | $23.03K | 8,425,824 |
| Robert Lawrence Golden Chief Financial Officer, Director | Jan 31, 2025 | Award | +24,272 | – | – | 169,572 |
| Jair Clarke Director | Jan 1, 2025 | Award | +82,143 | – | – | 93,485 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.